| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Benevich Eric is a Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $8.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 5,079 | $116.38 | $591,088.69 | -6.4% | |
| Jan 26, 2021 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 5,477 | $120.02 | $657,371.27 | -7.8% | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 2,257 | $90.71 | $204,722.99 | -11.5% | |
| Nov 2, 2020 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sale+OE | 20,595 | $96.53 | $1,987,971.51 | -57.3% | |
| Aug 5, 2020 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 2,257 | $118.85 | $268,254.16 | -12.8% | |
| Apr 24, 2020 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 1,934 | $99.45 | $192,337.85 | -12.7% | |
| Apr 15, 2020 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 8,632 | $94.65 | $817,017.94 | -42.7% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 2,030 | $103.32 | $209,747.31 | -9.2% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 3,349 | $102.38 | $342,872.07 | -6.1% | |
| Jul 15, 2019 | NBIX Neurocrine Biosciences Inc | Chief Commercial Officer | Sell | 5,835 | $87.44 | $510,201.31 | -28.1% |